María Virginia Reggiardo

Suggest Changes
Learn More
BACKGROUND Efficacy and safety of Pegylated Interferon alfa (PegIFN)-Ribavirin (RBV) for the treatment of chronic hepatitis C (CHC) in routine clinical practice seems to be comparable with results of(More)
  • 1